Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (141-150 of 270) with videos related to

Pageof 27
Sort By:
Journal of Virology|June 27, 2014
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cellsMaria J Buzon, Enrique Martin-Gayo, Florencia Pereyra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
AIDS Research and Human Retroviruses|December 6, 2012
Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmissionJiegang Huang, Junjun Jiang, Jonathan Z Li, et al.
Nature Biomedical Engineering|August 8, 2022
A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasmaDevora Najjar, Joshua Rainbow, Sanjay Sharma Timilsina, et al.
The Journal of Infectious Diseases|August 31, 2023
Long COVID After Bamlanivimab TreatmentTeresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
HIV Medicine|January 13, 2022
Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South AfricaJaysingh Brijkumar, Johnathan A Edwards, Brent A Johnson, et al.
Pageof 27

Showing results (141-150 of 270) with videos related to

Sort By:
Pageof 27
Journal of Virology|June 27, 2014
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cellsMaria J Buzon, Enrique Martin-Gayo, Florencia Pereyra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
AIDS Research and Human Retroviruses|December 6, 2012
Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmissionJiegang Huang, Junjun Jiang, Jonathan Z Li, et al.
Nature Biomedical Engineering|August 8, 2022
A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasmaDevora Najjar, Joshua Rainbow, Sanjay Sharma Timilsina, et al.
The Journal of Infectious Diseases|August 31, 2023
Long COVID After Bamlanivimab TreatmentTeresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
HIV Medicine|January 13, 2022
Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South AfricaJaysingh Brijkumar, Johnathan A Edwards, Brent A Johnson, et al.
Pageof 27